Escalon Medical Corp. (ESMC) Return on equity 2016–2025
Escalon Medical Corp. (ESMC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
5.5%FY2025 · since FY2016: -60.3% → 5.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 5.5% | +12.4 pp |
| FY2024 | -6.9% | -30.5 pp |
| FY2023 | 23.6% | +22.4 pp |
| FY2022 | 1.2% | +4.8 pp |
| FY2021 | -3.6% | +39.4 pp |
| FY2020 | -43.0% | -31.4 pp |
| FY2019 | -11.6% | -35.8 pp |
| FY2018 | 24.2% | +85.6 pp |
| FY2017 | -61.4% | -1.1 pp |
| FY2016 | -60.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice